How to Vet a Korean Cosmetic ODM Before You Sign: A Pre-PO Due Diligence Checklist for Indie K-Beauty Founders (2026)

By the ALTA MEET editorial team | K-beauty ODM consulting, Manhattan NYC × Seoul

Most indie founders who get burned by a Korean ODM did not pick a fraudulent factory. They picked a real one that was wrong for their brand. They paid for samples, signed a purchase order, wired a 50% deposit, and then discovered that the ODM did not actually run the production line for their category, that the per-unit price quoted at 1,000 units was actually contingent on 5,000 units, or that the "ISO 22716 GMP certified" line in the sales deck referred to a sister facility three hours from where their formula would be produced.

That outcome is preventable. There are thousands of Korean ODM facilities, the good ones are professional and welcoming to indie brands, and the bad-fit ones almost always reveal themselves during a structured 4- to 6-week vetting process before the first PO. Most founders skip that process because they do not know what to ask for, what counts as a red flag, or what a normal Korean ODM response looks like on each gate.

This post is the checklist. It assumes you have a defined product concept (category, target price, hero ingredients, claim direction) and 2 to 4 Korean ODM candidates you are seriously considering. It walks through nine vetting gates, in the order Liz uses them, with what a pass looks like, what a fail looks like, what to ask for in writing, and the documents to keep on file before you commit to a first PO.

Why Pre-PO Vetting Matters More in 2026 Than It Did Five Years Ago

Three things changed the math for indie K-beauty founders between 2020 and 2026.

First, the US regulatory floor moved. MoCRA 2022 made facility registration and product listing federally enforced for any cosmetic product sold in the United States, with a biennial renewal cycle. Facilities that registered by the initial July 1, 2024 deadline began renewing in early-to-mid 2026, and FDA updated Cosmetics Direct with a Registration Status field plus automated email reminders in February 2026. If your Korean ODM is not on top of facility registration and your US-based Responsible Person paperwork, the post-launch cleanup is expensive (US FDA, Cosmetics Registration and Listing, 2026).

Second, the EU regulatory floor moved. France's DGCCRF announced ISO 22716 will become compulsory by late 2026 or early 2027, and EU peer regulators are expected to follow. ISO 22716 was already widely held by serious Korean ODMs, but the move from "ISO 22716 recommended" to "ISO 22716 required" closes the gap on Korean facilities that historically operated below that bar (DGCCRF 2025; SGS, ISO 22716 Certification, 2026).

Third, the tariff and de minimis environment changed. The November 2025 US-Korea Strategic Trade and Investment Deal and the August 2025 end of the de minimis exemption mean indie brands can no longer rely on a small-parcel cost structure to absorb a wrong ODM choice. The per-unit cost of error is higher than it was 24 months ago.

The vetting protocol below is the version Liz has refined across the indie K-beauty brands altameet has placed with Korean ODMs in the last five years. It is not a "gotcha" sequence. It is the set of structured asks that separates ODMs that are a fit for your scale, your category, and your timeline from ones that will technically take your money but disappoint you on the other side.

Prerequisites Before You Start the Vetting Process

Skip this section only if you already have all five of the following:

  1. A written product brief for each SKU you want produced. At minimum: category, target price, target MOQ, hero actives and approximate concentrations, claim direction, exclusion list, packaging direction (airless vs. jar vs. tube), and your launch market. If you do not have a written brief, each Korean ODM you talk to will quote you a different product, and the vetting gates below will give noisy results. See our Korean ODM brief template for the version we use with first-time indie founders.

  2. A target landed cost for your launch SKU, computed end to end. Not just the ODM ex-works price. Include MoCRA Responsible Person fees, US Customs entry, the 15% reciprocal tariff applicable to Korean cosmetic HTS 3304 lines under the November 2025 Strategic Trade and Investment Deal, freight, warehousing, and a quality buffer. Our Korean skincare manufacturing cost guide walks through the full stack.

  3. A clear answer to "who is your US Responsible Person?" Under MoCRA, the Responsible Person is the manufacturer, packer, or distributor whose name appears on the product label. For a foreign-manufactured product, the US importer typically serves as Responsible Person, with a US Agent for FDA contact purposes. If you are still deciding whether you (the founder), your LLC, or a third-party regulatory firm will sign that line, decide before you start vetting. The ODM will ask.

  4. A timeline anchored to a real launch event (DTC launch date, retail PO, trade show). Vetting four ODMs in parallel is a five-figure investment in your time. If you do not have a real downstream deadline, you will drift, and the ODMs will deprioritize your inquiry against brands with confirmed timelines.

  5. Reference numbers from at least one other founder who has manufactured in Korea. Even a single 30-minute call with someone who has launched at the 1,000 to 5,000 MOQ tier will calibrate your sense of what is normal in the quote, sample, and lead-time conversations below. This is the cheapest input you will ever buy.

If you have all five, you are ready. If you do not, the vetting gates below will still work, but you will be more dependent on the ODM to do the brand-direction thinking for you, which weakens your position in every negotiation.

The 9-Step Pre-PO Vetting Checklist

Step 1: Verify the Legal and Regulatory Identity

Before you discuss product, verify the ODM exists in the way it says it does.

Ask the ODM for, and verify against the Korean public record:

  • Business registration number (사업자등록번호, 10-digit). This is the Korean equivalent of an EIN. Cross-check against the National Tax Service business registration lookup.

  • Cosmetics manufacturer registration with the Ministry of Food and Drug Safety (MFDS, formerly KFDA). Under the Korean Cosmetic Act, any facility that manufactures cosmetics for the domestic or export market must hold this registration. Ask for the registration number and the name of the registered facility (the "manufacturing place"). The MFDS-registered facility name and address should match where your formula will actually be produced.

  • Responsible Seller registration (책임판매업 등록증) if the ODM also sells finished goods, and the Functional Cosmetics Notification number for any whitening, anti-wrinkle, or sunscreen SKU you may want produced (MFDS, Cosmetics Approval Process, 2026).

  • Export license if you are sourcing finished goods rather than bulk formula.

Pass: ODM sends scans of the actual certificates within two business days, with the facility name and address matching what they have described to you.

Fail: ODM hesitates, sends the certificates of a sister facility, or sends only marketing materials and brochures. A serious Korean ODM has these documents in a shared client onboarding folder and can send them within hours.

Step 2: Confirm GMP Certification and the Specific Facility Where Your Formula Will Run

This is the single most common founder mistake. Many Korean ODM groups operate multiple manufacturing sites. The site that holds the most-cited ISO 22716 or KFDA GMP certificate is not always the site that will physically produce your product.

Ask for, and verify:

  • ISO 22716 certificate (cosmetic GMP). Valid for a maximum of three years; certified by an ISO 17065 accredited body. Check the issuing body's online verification database. Most reputable certifiers maintain a public lookup (SGS, ISO 22716 Certification, 2026; Eurofins, Cosmetic GMP Certification, 2025).

  • KFDA / MFDS GMP certificate for cosmetics (the Korean domestic GMP framework, aligned to ISO 22716 since 2012).

  • The specific manufacturing place where your formula will be compounded, filled, and packed. Get this in writing in the quote.

Pass: Certificate is current (within 3-year window), certifier is ISO 17065 accredited, certifier's online database confirms the certificate number, and the certificate-holder's address matches the address where your formula will be produced.

Fail: Certificate expired, certifier is not accredited or not externally verifiable, or the certificate is held by a parent entity and the actual production line is at a sister facility you have not been told about. The fact that an ODM has any certificate at all is not enough; the certificate has to cover the specific facility producing your product.

If you are exporting to the EU, also ask whether the facility is preparing for the late-2026 / early-2027 DGCCRF requirement to make ISO 22716 mandatory. A facility that is not preparing is a facility that may scramble to maintain its certificate exactly when you need stable production.

Step 3: Confirm the Facility Has Run Your Category and Format Before

Korean ODMs vary significantly in category strength. A facility excellent at toner and essence may have weaker capability on emulsion stability or sunscreen photostability. A facility that runs 10,000-unit lots for established brands may be uncomfortable with the SKU-count and MOQ profile of an indie launch.

Ask:

  • "Of the last 12 months of production, what percentage of volume was in my category (cream, serum, sunscreen, etc.)?"

  • "Can you show me 3 currently-shipping reference SKUs in my category that you produced, with the brand names where the brand permits disclosure?"

  • "What is the smallest production run you have done in the last 6 months in my category?"

Pass: ODM names 2 or 3 reference brands, describes recent small-batch runs at or below your target MOQ, and matches your category to a specific production line at a specific facility.

Fail: ODM speaks generically, names only large established brand clients (which usually means they do not regularly take indie SKUs at low MOQs), or says yes to every category you raise. "We do everything" is rarely true for the line that will run your formula.

Step 4: Run a Realistic MOQ and Cost Quote

The quote conversation is also a vetting test. Ask each candidate ODM for a written quote that includes, line by line:

  • Bulk formula cost per unit at your target MOQ

  • Primary packaging cost per unit (bottle, cap, dropper, applicator) with the actual packaging vendor and SKU

  • Secondary packaging cost per unit (carton, insert, sticker)

  • Labeling cost (separate from secondary packaging, especially for multi-market labeling)

  • Filling, assembly, and QC cost per unit

  • Stability testing cost (ICH Q1A(R2) accelerated 40°C/75% RH + real-time 25°C/60% RH; ICH Q1B photostability if relevant) - this is often $1,500 to $4,000 per SKU, billed once

  • Microbial testing cost (ISO 17516:2014 limits: 1,000 CFU/g leave-on, 100 CFU/g eye/pediatric/mucosal) - typically $200 to $500 per batch

  • Packaging compatibility testing if the formula has reactive ingredients (retinoids, vitamin C, AHAs)

  • MOQ for each component, separately. The bulk MOQ, the bottle MOQ, the carton MOQ, and the label MOQ are usually different numbers. The highest one controls.

  • Lead time to first delivery, broken into formulation lock, packaging lead time, stability program, and production

  • Payment terms (typically 30/40/30 or 50/50 deposit/balance)

  • Per-unit price at 2 or 3 MOQ tiers (your target, plus the next step up) so you understand the cost curve

See our Korean ODM quote line-by-line guide for how to read each line.

Pass: Quote arrives within 5 to 10 business days, separates bulk, packaging, testing, and labor, names component MOQs explicitly, and quotes 2 or more MOQ tiers.

Fail: Quote is a single all-in number with no line-item breakdown; quote does not mention stability or microbial testing at all; quote arrives with a much lower bulk number than competitors but no packaging or testing line items (the rest will appear in the second quote, after you are emotionally committed).

I'm Liz, I run altameet from Manhattan, NYC. The single biggest pattern I see in indie founder regret around Korean ODMs is signing on a low all-in number, then watching stability testing, packaging MOQs, and labeling appear as separate invoices after the deposit clears. The vetting fix is mechanical: ask for the line-itemed quote at Step 4, and walk away from any ODM that will not produce one. If you want a quick gut-check on a quote you have on your desk right now, grab 15 minutes free with me and I will look at it line by line.

Step 5: Request and Evaluate a First Sample (Not a Stock Sample)

Most Korean ODMs will send you stock samples (their own catalog formulas) for free. Stock samples tell you the facility can produce a finished product. They do not tell you whether the facility can produce your product.

The vetting sample is a paid custom sample, not a stock sample. Ask for:

  • A first-pass custom formulation following your brief

  • A written formulation rationale: what they reformulated, what they substituted, what they think is risky

  • An ingredient list at the trade-name level for your reference (you do not need the full %INCI yet; that comes after NDA + first PO at most facilities)

  • Microbial test result, even a preliminary one, on the sample

  • A clear sense of what they would change in the next iteration

Expect to pay $300 to $1,500 per SKU for a custom sample, depending on category complexity. Refusing to pay for samples filters you down to the ODMs that prioritize indie brands willing to spend money for a real custom sample.

Pass: Sample arrives within 3 to 6 weeks, with a written rationale, an honest set of caveats ("we substituted ingredient X because the one in your brief sits at $90/kg and would push the per-unit cost above your target"), and at least one iteration cycle built into the proposed timeline.

Fail: ODM ships a relabeled stock sample, refuses to charge for the custom sample (usually a sign they will not invest the chemist time), or sends the sample with no rationale and no openness to iteration.

Step 6: Run a Quality and Stability Documentation Test

Ask the ODM to send you, for one of their currently-shipping reference SKUs in your category, the redacted documentation that a downstream brand would receive:

  • Certificate of Analysis (COA) from a recent production batch

  • Microbial test report against ISO 17516:2014 limits

  • Stability testing summary following ICH Q1A(R2) (accelerated 40°C/75% RH for 3 months, plus real-time 25°C/60% RH)

  • Photostability summary under ICH Q1B if the SKU contains photosensitive actives (retinol, retinal, vitamin C, encapsulated ingredients)

  • Preservation Efficacy Test (PET) following ISO 11930

You do not need the original brand's data. You need to see that the ODM has the documentation infrastructure to produce these reports.

Pass: ODM sends redacted reports within 3 to 5 business days, formatted as a standard QC packet, with test methods cited.

Fail: ODM sends a single COA with no underlying test methods, or says they "can produce these reports if needed but do not have them on hand for past production." That answer means the documentation is built ad hoc for export, which is a red flag for any indie brand that will be subject to MoCRA recordkeeping or EU CPNP requirements.

Step 7: Audit the Communication Workflow Before You Audit the Factory

You do not need to fly to Seoul to vet an ODM. You do need to test the communication workflow that you will be running for 6+ months after you sign.

Test for:

  • Response time. Most professional Korean ODMs respond to client emails within 1 business day (Korea Standard Time = UTC+9). New York business hours overlap with Korean business hours for ~2 hours per day (5 to 7am ET). A quote-stage ODM that takes 4 to 5 business days to respond will not be faster in production. This is the same person and the same workflow.

  • English documentation quality. Quote, COA, MoCRA-aligned ingredient list, labeling proof. A facility where the export team writes in fluent technical English will save you weeks of rework. A facility where the export team translates each document through a free machine translator and sends you "kindly check please" emails will cost you weeks.

  • Single point of contact. Confirm who your account manager will be. Confirm what happens during their vacation, their parental leave, or their resignation. ODMs that change account managers mid-production are a known indie-founder pain point.

  • Document versioning. Quote v3, Formula v5, Label v2. A serious ODM versions documents. A facility that emails you "the latest one is the one with the timestamp" will create version-control problems on the production floor.

Pass: Email responses within 1 to 2 business days, clean English technical documents, named single point of contact, versioned attachments.

Fail: Response times of 4+ days, machine-translated emails, no named account manager, no version control.

Step 8: Verify the Path to MoCRA and US Market Compliance

For US-bound product, the ODM does not need to be your Responsible Person, but they do need to fit your Responsible Person workflow.

Confirm:

  • The ODM understands MoCRA and has produced product for at least one Responsible Person registered under MoCRA. Ask which.

  • The ODM can provide a MoCRA-aligned ingredient list at INCI level, in the order required by FDA labeling rules, with allergen disclosure under EU Annex III where you want unified labeling.

  • The ODM can provide adverse event reporting support and safety substantiation documentation.

  • The ODM is willing to be listed on your facility registration as a "manufacturing/processing" facility, with the facility name, address, and DUNS or FEI number. Foreign manufacturing facilities are subject to the same biennial facility registration as domestic facilities (US FDA, Cosmetics Registration and Listing, 2026; Crowell & Moring, FDA MoCRA Final Guidance, 2024).

For more on the full MoCRA setup, see our FDA Korean skincare import guide and the MoCRA compliance checklist.

Pass: ODM names another US brand they produce for, explains its Responsible Person setup at a high level, and confirms willingness to be listed on facility registration.

Fail: ODM does not know what MoCRA is, has never had a US-facing client of any size, or cannot produce a MoCRA-aligned ingredient list.

Step 9: Check IP, NDA, and Exit Terms Before You Sign

The last gate is contractual. The ODM contract you sign before first PO defines what happens when things go right and when things go wrong.

Confirm in writing:

  • Formula ownership. Custom-developed formula belongs to the brand, or belongs to the ODM, or is jointly held. The default at many Korean ODMs is that custom formulas paid for by the brand are co-owned, meaning the ODM can use the formula with other clients. Negotiate exclusivity for hero formulas if you can; exclusivity often costs an upfront fee or a usage premium per unit.

  • Mutual NDA covering brand confidentiality (your formula, your launch plan) and ODM confidentiality (their reference brands, their cost structure).

  • Sample retention (typically 2 years per batch under Korean and EU norms; ICH retention guidance is the underlying framework).

  • Recall and exit terms. What happens if a batch fails QC? What is the rework cost? What happens if you want to leave the ODM and take the formula?

  • Force majeure terms for shipping disruptions, raw material shortages, and regulatory changes (the 2025 tariff and de minimis changes are the recent precedent).

Pass: ODM sends a standard contract template within 1 week, openly negotiates formula ownership, includes mutual NDA, and has clear exit language.

Fail: Contract is a 1-page PO with no formula ownership clause, no NDA, no recall language, and no exit terms. This contract favors the ODM in every dispute.

Five Common Mistakes Indie Founders Make During Vetting

Mistake 1: Vetting only one ODM at a time. Vet 2 to 4 ODMs in parallel. Otherwise you cannot calibrate what a normal response looks like at each gate.

Mistake 2: Skipping the line-item quote because the all-in number "feels right." The all-in number is rarely the all-in number. Force the line items.

Mistake 3: Falling for stock samples. A stock sample tells you the facility makes finished product. It does not tell you the facility can make your product. Pay for the custom sample.

Mistake 4: Letting the ODM choose your packaging. Many Korean ODMs work with a preferred packaging vendor and will quietly default you to that vendor's bottle. Ask for 2 or 3 packaging options at different unit prices and lead times before locking in.

Mistake 5: Confusing speed-of-response with priority. A Korean ODM that responds in 2 hours during the vetting phase, then takes 5 days during production, is common. The reverse (slow during vetting, fast during production) is rare. The vetting-phase response time is roughly the floor of the production-phase response time, not the ceiling.

Timeline: What This Looks Like Over 4 to 6 Weeks

A realistic vetting timeline for an indie founder running 3 ODMs in parallel:

  • Week 1. Send brief, request quotes, request regulatory documents (Steps 1, 2, 3).

  • Week 2. Receive initial quotes, review line items, send second-round questions (Step 4).

  • Week 3. Pay for custom samples; receive QC documentation packets from each candidate (Steps 5, 6).

  • Week 4. Receive and evaluate first custom samples; run sensory and stability spot-checks.

  • Week 5. Run MoCRA, IP, and contract conversations; align on US Responsible Person workflow (Steps 7, 8, 9).

  • Week 6. Final decision and first PO.

If you are running this in parallel with EU CPNP registration or KFDA Functional Cosmetics notification, add 4 to 8 weeks for the regulatory program to come back. Build that into the launch plan.

Variations: Pre-Seed Brand vs. Growing Brand

The vetting protocol does not change. Your negotiating position does.

Pre-seed indie founder (first SKU, 1,000 to 3,000 MOQ): You will have less negotiating room on formula exclusivity, less room on payment terms, and less room on lead-time guarantees. Use the vetting protocol to find the ODM that is professionally indifferent to size and willing to onboard you cleanly. Most large established Korean ODMs are not the right fit at this stage. The right fit is usually a mid-size ODM that runs an indie-friendly line at 1,000 to 3,000 MOQ alongside larger contracts.

Growing indie brand (2nd to 5th SKU, 5,000 to 20,000 MOQ): Your negotiating room rises sharply. Formula exclusivity is negotiable. Stability testing fees can sometimes be absorbed into the unit price. You can ask for a named QC representative on each batch. Use the vetting protocol to confirm the ODM can support your next SKU's category, not just the one you launched with.

Established indie brand (6th SKU+, 20,000+ MOQ, retail PO direction): The vetting protocol gets compressed (steps 1, 2, 8, 9 still matter; steps 3, 5, 7 are mostly settled). Add a real factory audit, in person or via a third party, especially before signing on a retail-facing PO that exposes you to chargeback risk.

Founder Decision Criteria

The output of vetting is a decision matrix across the 9 gates. The matrix below is the version Liz uses:

Gate Pass = Weight Legal identity verified All certificates current, verifiable High GMP at the right facility Cert covers the actual production line High Category fit 3+ reference SKUs in category High Line-item quote Bulk, packaging, testing, labor separated High Custom sample quality Paid, written rationale, iteration path Medium QC documentation maturity Redacted COA + stability + PET available High Communication workflow <2 day responses, single POC, versioned docs Medium MoCRA / US compliance fit Named US client, willing to be listed High IP, NDA, exit terms Standard contract, exclusivity negotiable Medium

An ODM that fails on a high-weight gate is not negotiable. An ODM that fails on a medium-weight gate is sometimes still the right choice if everything else is strong. The exception is the line-item quote (medium weight on first look, high weight in practice): in our experience, an ODM that will not produce a line-itemed quote will produce surprise invoices for stability testing, packaging adjustments, and labeling rework after the first PO.

Key Takeaways

  1. Pre-PO vetting is the cheapest insurance an indie K-beauty founder buys. The cost is 4 to 6 weeks and 2 to 4 paid custom samples.

  2. The 9 gates are: legal identity, GMP at the right facility, category fit, line-item quote, paid custom sample, QC documentation, communication workflow, MoCRA fit, IP and contract terms.

  3. The single most common failure mode is signing on an all-in quote that hides stability, microbial, packaging MOQ, and labeling costs. Force the line items.

  4. The single most common documentation failure is treating a parent-entity ISO 22716 certificate as proof that the line running your formula is certified. Verify the facility name.

  5. Vet 2 to 4 ODMs in parallel. One ODM gives you no calibration.

  6. The vetting-phase communication workflow is the floor of the production-phase workflow, not the ceiling.

FAQ

Q1: Can I skip the custom sample step if I am only making 1,000 units of a Test SKU? At 1,000 units, the per-unit cost of a wrong formulation is roughly $4 to $9. Across 1,000 units, that is $4,000 to $9,000 of inventory you cannot sell. A $500 to $1,500 paid custom sample is the right investment relative to that exposure. The only case where it is reasonable to skip is when you have personally inspected and approved a relabeled stock formula that you are confident will sell as-is.

Q2: How do I verify a Korean business registration number from the US? The National Tax Service of Korea provides a public business registration lookup (사업자 등록상태 조회) at the hometax.go.kr site. The lookup confirms whether the registration is currently active and matches the company name. For deeper checks (corporate registry, directors, financial filings), the Korean Court Registry (iros.go.kr) provides paid corporate extracts. Most US founders find the National Tax Service lookup sufficient for initial vetting; the Court Registry extract is useful at contract stage.

Q3: How many Korean ODMs do indie K-beauty founders typically vet? Three to four is the right number. Two leaves you without calibration; five or more is usually too much email volume to manage in parallel as a solo founder. If you find yourself wanting to vet six, the more useful filter is upstream: tighten the brief.

Q4: How much does the vetting process cost? The hard costs are typically $1,500 to $5,000: 2 to 4 paid custom samples ($300 to $1,500 each), shipping, optional translator support, and an occasional Korean Court Registry extract. The opportunity cost (founder time) is meaningfully larger. Budget 30 to 50 hours of founder time spread over 4 to 6 weeks.

Q5: Is an in-person factory audit required? Not for the first 1,000 to 5,000 unit PO. It is reasonable for the second-year, larger-MOQ relationship, especially before signing into a retail PO. A third-party audit firm (industry rate: $1,500 to $4,000 per audit) is a common middle ground. Cost-quality and food-grade audit firms with cosmetic experience operating in Seoul exist; ALTAMEET can introduce founders to vetted ones when relevant.

Q6: What does the ODM expect from a US indie founder during vetting? Korean ODMs prefer indie founders who arrive with a written brief, a real timeline, a clear MoCRA Responsible Person plan, and a decision-maker who can act within 24 to 48 hours on each gate. Founders who arrive without these are not refused, but they are quoted longer lead times and looser pricing because the ODM is absorbing more uncertainty.

Q7: How is this different from the OEM / ODM / Private Label decision? The vetting protocol applies to all three models. Whether you are doing private label off a stock formula (OEM), commissioning a custom formula (ODM), or running a hybrid, you still need to verify legal identity, GMP at the right facility, and MoCRA fit. The decision matrix weights shift: for private label, the custom sample step is less critical; for ODM, the IP and exclusivity step is more critical. See our OEM vs ODM vs Private Label guide for the model comparison.

Reviewed for accuracy by ALTA MEET's formulation consulting team.

Working With ALTA MEET

ALTAMEET is a boutique K-beauty manufacturing partner based in Manhattan, NYC, with Seoul-side oversight. We run the 9-step vetting protocol above as the first phase of every founder engagement, with the ODMs we already know and the ones our founders bring to the table. If you are 4 to 6 weeks out from a first PO with a Korean ODM and want a second pair of eyes on the quotes, the samples, or the contract, book a free 15-min K-Beauty manufacturing gut-check with Liz. We will read the documents you have, flag the gates that need more weight, and tell you what we would do next.

Previous
Previous

Centella Asiatica in Korean Skincare: Madecassoside Sourcing for Indie Brands (2026)

Next
Next

US Tariffs on Korean Cosmetics in 2026: What the 15% Reciprocal Rate, KORUS, and the End of De Minimis Mean for Indie K-Beauty Brand Cost Math